Navigation Links
Global Hospital Infection Therapeutics Market 2015-2019 - Development of Multidrug Resistant Variants Is a Key Market Driver
Date:11/4/2015

DUBLIN, Nov. 4, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2wrs67/global_hospital) has announced the addition of the "Global Hospital Infection Therapeutics Market 2015-2019" report to their offering.

Covered in this report

The report covers the present scenario and growth prospects of the global hospital infection therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of drugs used in the treatment of various hospital-acquired infections such as bloodstream infections, Clostridium difficile infections, hospital-acquired pneumonia, surgical site infections, and urinary tract infections.

Patient assistance programs are expected to boost the growth of the market during the forecast period. Vendors provide co-pay assistance to individuals who purchase the indicated drugs for treating infections. Pfizer's drug Zyvox has a co-pay assistance program to provide financial assistance.

According to the report, surgeries for cardiac, renal, and gastrointestinal disorders and cesarean section for childbirth are commonly performed currently. Many individuals also choose esthetic enhancement surgeries such as maxillofacial and prosthetic surgeries. This leads to increased exposure to microbes in the hospital environment, thus leading to infections and other complications. Surgeries increase the length of stay in the hospital and individuals are at greater risk of contracting infections.

Further, the report states that generic drugs are similar in quality, dosage form, strength, and efficacy to branded drugs, but are available at lower prices. A branded drug can be manufactured as generic after losing its patent. Many of the anti-infective drugs such as ceftriaxone, ampicillin, ampicillin and sulbactam, and ertapenem, are available as generics in the market.

Key vendors

  • Allergan
  • Bayer
  • GlaxoSmithKline
  • Merck
  • Pfizer

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Disease overview

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by drug class

PART 09: Market segmentation by type of infections

PART 10: Geographical segmentation

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendor analysis

For more information visit

http://www.researchandmarkets.com/research/2wrs67/global_hospital

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019 with GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck & Co & Tesaro Dominating
2. Global Smart Pills Market 2015 Research Reports With 2021-24 Forecasts
3. Global Cardiovascular Partnering 2010-2015: Deal trends, players and financials - Reportlinker Review
4. Global Drug Delivery in Central Nervous System Diseases Report 2015-2019 & 2024
5. Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025
6. North America Leads Global Home Healthcare Market, but Asia Pacific not Far Behind: Transparency Market Research
7. Global Wearable Medical Device Market - Growth, Trends and Forecasts (2015-2020)
8. Anesthesia Monitoring Devices Market by Product, End User, and Geography - Global Forecast to 2020
9. Global Alpha Emitters Market - Growth, Trends and Forecasts (2015 - 2020)
10. Global Pharmaceutical Packaging Market 2015-2019 - Reportlinker Review
11. Cardiac Pacemaker Market 2020 Forecasts for Global and Regional Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2019)... ... November 14, 2019 , ... Algae Health Sciences, ... clinical trials using AstaZine® on brain health. , In the first ... depression, mental fatigue and overall mood state [psychological well-being] were found after 8 ...
(Date:11/14/2019)... , ... November 14, 2019 , ... ... clinical trials, announced today that it has reached a milestone in the company’s ... more than 200 regulatory submissions from biopharmaceutical clients for therapies and indications subsequently ...
(Date:11/12/2019)... MILFORD, Ohio (PRWEB) , ... November 12, 2019 ... ... announced the opening of a new medication-assisted treatment (MAT) facility in the Cincinnati, ... opioid addiction including medication, counseling and support services. The clinic, located at 749C ...
Breaking Medicine Technology:
(Date:11/11/2019)... ... November 11, 2019 , ... Smile Brands Inc., one of ... United States, today announced the grand opening of another affiliated Bright Now! ... convenient hours, comfortable offices and full-service care at the new location. The newest ...
(Date:11/11/2019)... ... November 11, 2019 , ... Last year’s expo was ... countries including big box buyers like Costco, Walmart, and GNC. Exhibitors included some ... name a few. , This year, CBD.io and partners, are once ...
(Date:11/11/2019)... ... November 11, 2019 , ... Artemis, ... prevention and urges increased adoption of compliance technology in the wake of the ... sold to select retailers in the United States and Canada due to potential ...
(Date:11/11/2019)... , ... November 11, 2019 , ... PracticeLink Live! Atlanta ... Downtown. The event will begin at 5:00 p.m. and continue until 8:00 p.m. A ... Your Job Search, will begin at 6:30 p.m. , Both the career fair and ...
(Date:11/9/2019)... ... November 08, 2019 , ... Pennsylvania College of Health ... announce that after the fourth quarter of the 2018-2019 academic year, the school’s ... pass rate. The College’s annual pass rate for the 2018-2019 academic year was ...
Breaking Medicine News(10 mins):